identified DOCK9, PTGFR, NREP, SCARNA22, FLVCR2, CLASP1, IK2F3, and USP13 as potential biomarkers predicting the progression of PCa, especially between stage II and subsequent stages (123). This evidence concerns the gene SCARNA22 and posterior cortical atrophy.